LLY compared with ABCL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ABCLAbCellera Biologics Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ABCLAbCellera Biologics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only ABCL 3

BRKRBrukercustomer

PRLDPrelude Therapeuticssupplier

RLYBRallybiocustomer

Role chip = supplier or customerSource: SEC EDGAR

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,360.09· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ABCLAbCellera Biologics Inc.

11.90▲+6.87%· post 11.90· delayed

After hoursNov 6 '26delayed

Mkt cap$3.4BRevenue$4MQ2 FY26Revenue$75MFY25

Compare

After hoursNov 6 '26delayed

LLYELI Lilly & Co

ABCLAbCellera Biologics Inc.

1,360.90▼−0.28%post 1,360.09delayed

Price

11.90▲+6.87%post 11.90delayed

$1.2T

Mkt cap

$3.4B

Q3 FY26$24.4B

Revenue

$4MQ2 FY26

FY25$65.2B

Revenue

$75MFY25

LLY1,360.90▼−0.28%vsABCL11.90▲+6.87%After hoursNov 6 '26delayed